INSPECTING ARCHIVED INTELLIGENCE (OUTDATED VERSION).

Hyflock Publishes New Victim Merkezilac Archives

| 2026-10-13 17:10 CRITICAL HIGH RANSOMWARE & EXTORTION
Executive Summary
AI-generated
On October 13, 2026, a cyber operation targeting the pharmaceutical and hygiene/disinfection product manufacturer Merkez İlaç was detected. The company is one of the oldest local pharmaceutical factories in modern Turkey, with nearly a century of history, founded in 1934. The attack appears to be related to the "FortiBleed" vulnerability (CVE-2022-40684), which exposed FortiOS SSL-VPN credentials via a DNS leak. This has affected over 9,500 hospitals and clinics in Turkey that rely on Merkez İlaç for medical supplies and surgical/first aid consumables. The attack is believed to be carried out by Hyflock, who recently published the victim's domain as part of their publicly visible information index.
Technical Mitigations AI-generated
• Apply the vendor fix for CVE-2022-40684 and treat internet-facing systems that were not patched in time as potentially compromised until verified. • Reset credentials and API keys that may have been exposed, and review access logs for the affected accounts or integrations.
Intelligence Metadata
Actors / Malware / CVEs / Campaigns
CVE-2022-40684CVE-2022-40684
Target & Sectors
Global Scope retailretail manufacturingmanufacturing healthhealth pharmaceuticalpharmaceutical
Incident Timeline
‎2026/10/13
FortiBleed Exposure Detected via CVE-2022-40684 exposed the domain's FortiOS SSL-VPN credentials.
organisation FortiBleed Exposure Detected
organisation CVE-2022
organisation Scale •
organisation • Certification Standards: Production
organisation Good Manufacturing Practice
organisation Good Laboratory Practice
organisation ISO 9001
organisation Core Products and Business Merkez İlaç
organisation • Produces
organisation Opakjel
organisation Starbaz
organisation First Aid and Medical Consumables: •
organisation CMO
organisation Red Crescent
organisation DNS
Intelligence Sources